secwatch.observer — SEC 8-K summary
======================================

Issuer:     INVO Fertility, Inc. (IVF)
CIK:        0001417926
Form:       8-K
Filed at:   2024-10-15T23:59:59+00:00
Accession:  0001493152-24-041062
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.85
Item codes: 1.01, 5.03, 2.01, 3.02, 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INVO Bioscience completes acquisition of NAYA, changes name to NAYA Biosciences
-------------------------------------------------------------------------------

- NAYA stockholders receive 118,148 INVO common shares and 30,375 Series C-1 Preferred per share.
- $8.58M NAYA debt converted into 669,508 INVO common shares and 8,576 Series C-2 Preferred.
- Remaining $3.93M NAYA debt exchanged for 7% convertible debenture due December 2025.
- Name changed to NAYA Biosciences, Inc.; ticker to change from INVO to NAYA on Nasdaq.
- Dr. Daniel Teper appointed President and board director; Lyn Falconio also named to board.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1417926/000149315224041062/0001493152-24-041062-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1417926/000149315224041062/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-041062

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer